RIP-2 Kinase Inhibitor (DCAM Pharma)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameRIP-2 Kinase Inhibitor (DCAM Pharma)
Drug Alias NameRIP-2 Kinase Inhibitor (DCAM Pharma)DCAM-389DCAM-253DCAM-449
ClassificationSmall molecules
Mechanisms of ActionSerine/threonine-protein kinase RIPK2 inhibitors
TargetsSerine/threonine-protein kinase RIPK2
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDCAM Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDCAM Pharma Inc
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A